(Circulation. 1995;92:2911-2918.)
© 1995 American Heart Association, Inc.
Articles |
From I Clinica Medica, University of Pisa, and the Metabolism Unit, CNR Institute of Clinical Physiology (A.N., E.F.), Pisa, Italy.
Correspondence to Dr Stefano Taddei, I Clinica Medica, University of Pisa, Via Roma 67, 56100 Pisa, Italy.
Background The present study was designed to directly test the vasodilation action of insulin and its relation to endothelium-dependent mechanisms.
Methods and Results In 18 normotensive subjects and 27 patients with untreated mild to moderate essential hypertension, we studied the effect of intrabrachial insulin on the changes in forearm blood flow (strain-gauge plethysmography) induced by intrabrachial acetylcholine (at doses of 0.15, 0.45, 1.5, 4.5, and 15 µg · min-1 · dL-1), an endothelium-dependent vasodilator, or sodium nitroprusside (at doses of 1, 2, and 4 µg · min-1 · dL-1), an endothelium-independent vasodilator. Local hyperinsulinemia (deep venous plasma insulin, 48±6 and 51±5 µU/mL in control subjects and hypertensive patients, respectively) did not affect basal forearm blood flow and stimulated forearm glucose extraction (control subjects, 3±1% to 11±2%, P<.001; hypertensive patients, 3±1% to 6±1%, P<.001; P<.01 for the between-group difference). In both normotensive and hypertensive subjects, insulin significantly potentiated acetylcholine-induced vasodilation, whereas it did not alter the vasodilatory response to sodium nitroprusside. NG-monomethyl-L-arginine, an inhibitor of endothelial nitric oxide synthesis, blunted insulin-induced facilitation of acetylcholine vasodilation in normotensive but not in hypertensive subjects. In contrast, in hypertensive patients but not in normotensive control subjects, the potentiation of the vascular response to acetylcholine induced by local hyperinsulinemia was abolished by intrabrachial ouabain, an inhibitor of Na+-K+ pump.
Conclusions In healthy humans and essential hypertensive patients alike, local physiological hyperinsulinemia per se does not increase forearm blood flow but potentiates the vasodilation induced by acetylcholine regardless of metabolic insulin resistance. This effect is endothelium-dependent because it is not seen with nitroprusside and is related to the L-argininenitric oxide pathway in normotensive subjects and to smooth muscle cell hyperpolarization in essential hypertensive patients.
Key Words: insulin acetylcholine blood flow endothelium-derived factors
This article has been cited by other articles:
![]() |
I. Fleming Double Tribble: Two TRIB3 Variants, Insulin, Akt, and eNOS Arterioscler. Thromb. Vasc. Biol., July 1, 2008; 28(7): 1216 - 1218. [Full Text] [PDF] |
||||
![]() |
I. Sudano, A. Virdis, S. Taddei, L. Spieker, R. Corti, G. Noll, A. Salvetti, and T. F. Luscher Chronic Treatment With Long-Acting Nifedipine Reduces Vasoconstriction to Endothelin-1 in Essential Hypertension Hypertension, February 1, 2007; 49(2): 285 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Schramm, T. Dinh, and A. Veves Microvascular changes in the diabetic foot. International Journal of Lower Extremity Wounds, September 1, 2006; 5(3): 149 - 159. [Abstract] [PDF] |
||||
![]() |
S. Taddei, D. Versari, A. Cipriano, L. Ghiadoni, F. Galetta, F. Franzoni, A. Magagna, A. Virdis, and A. Salvetti Identification of a Cytochrome P450 2C9-Derived Endothelium-Derived Hyperpolarizing Factor in Essential Hypertensive Patients J. Am. Coll. Cardiol., August 1, 2006; 48(3): 508 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Vincent, L. H. Clerk, J. R. Lindner, W. J. Price, L. A. Jahn, H. Leong-Poi, and E. J. Barrett Mixed meal and light exercise each recruit muscle capillaries in healthy humans Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1191 - E1197. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Hermann, W. Li, H. Dominguez, N. Ihlemann, C. Rask-Madsen, A. Major-Pedersen, D. B. Nielsen, K. W. Hansen, M. Hawkins, L. Kober, et al. Quinapril Treatment Increases Insulin-Stimulated Endothelial Function and Adiponectin Gene Expression in Patients with Type 2 Diabetes J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1001 - 1008. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sydow, C. E Mondon, and J. P Cooke Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA Vascular Medicine, May 1, 2005; 10(2_suppl): S35 - S43. [Abstract] [PDF] |
||||
![]() |
M. A. Vincent, L. H. Clerk, J. R. Lindner, A. L. Klibanov, M. G. Clark, S. Rattigan, and E. J. Barrett Microvascular Recruitment Is an Early Insulin Effect That Regulates Skeletal Muscle Glucose Uptake In Vivo Diabetes, June 1, 2004; 53(6): 1418 - 1423. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Randriamboavonjy, J. Schrader, R. Busse, and I. Fleming Insulin Induces the Release of Vasodilator Compounds From Platelets by a Nitric Oxide-G Kinase-VAMP-3-dependent Pathway J. Exp. Med., February 2, 2004; 199(3): 347 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, M. A. Vincent, S. M. Richards, L. H. Clerk, S. Rattigan, M. G. Clark, and E. J. Barrett Insulin Sensitivity of Muscle Capillary Recruitment In Vivo Diabetes, February 1, 2004; 53(2): 447 - 453. [Abstract] [Full Text] |
||||
![]() |
J. Westerbacka, R. Bergholm, M. Tiikkainen, and H. Yki-Jarvinen Glargine and Regular Human Insulin Similarly Acutely Enhance Endothelium-Dependent Vasodilatation in Normal Subjects Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 320 - 324. [Abstract] [Full Text] |
||||
![]() |
S. Vehkavaara and H. Yki-Jarvinen 3.5 Years of Insulin Therapy With Insulin Glargine Improves In Vivo Endothelial Function in Type 2 Diabetes Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 325 - 330. [Abstract] [Full Text] |
||||
![]() |
T. S. Hermann, C. Rask-Madsen, N. Ihlemann, H. Dominguez, C. B. Jensen, H. Storgaard, A. A. Vaag, L. Kober, and C. Torp-Pedersen Normal Insulin-Stimulated Endothelial Function and Impaired Insulin-Stimulated Muscle Glucose Uptake in Young Adults with Low Birth Weight J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1252 - 1257. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sundell and J. Knuuti Insulin and myocardial blood flow Cardiovasc Res, February 1, 2003; 57(2): 312 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tamminen, J. Westerbacka, S. Vehkavaara, and H. Yki-Jarvinen Insulin-Induced Decreases in Aortic Wave Reflection and Central Systolic Pressure Are Impaired in Type 2 Diabetes Diabetes Care, December 1, 2002; 25(12): 2314 - 2319. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Serne, R. G. IJzerman, R. O.B. Gans, R. Nijveldt, G. de Vries, R. Evertz, A. J.M. Donker, and C. D.A. Stehouwer Direct Evidence for Insulin-Induced Capillary Recruitment in Skin of Healthy Subjects During Physiological Hyperinsulinemia Diabetes, May 1, 2002; 51(5): 1515 - 1522. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sundell, P. Nuutila, H. Laine, M. Luotolahti, K. Kalliokoski, O. Raitakari, and J. Knuuti Dose-Dependent Vasodilating Effects of Insulin on Adenosine-Stimulated Myocardial Blood Flow Diabetes, April 1, 2002; 51(4): 1125 - 1130. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dawes, C. Sieniawska, T. Delves, R. Dwivedi, P. J. Chowienczyk, and J. M. Ritter Barium Reduces Resting Blood Flow and Inhibits Potassium-Induced Vasodilation in the Human Forearm Circulation, March 19, 2002; 105(11): 1323 - 1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kimura, A.-M. Jefferis, H. Watanabe, and J. Chin-Dusting Insulin Inhibits Acetylcholine Responses in Rat Isolated Mesenteric Arteries via a Non-Nitric Oxide Nonprostanoid Pathway Hypertension, January 1, 2002; 39(1): 35 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Coggins, J. Lindner, S. Rattigan, L. Jahn, E. Fasy, S. Kaul, and E. Barrett Physiologic Hyperinsulinemia Enhances Human Skeletal Muscle Perfusion by Capillary Recruitment Diabetes, December 1, 2001; 50(12): 2682 - 2690. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gaenzer, W. Sturm, G. Neumayr, R. Kirchmair, C. Ebenbichler, A. Ritsch, B. Foger, G. Weiss, and J. R Patsch Pronounced postprandial lipemia impairs endothelium-dependent dilation of the brachial artery in men Cardiovasc Res, December 1, 2001; 52(3): 509 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rask-Madsen, N. Ihlemann, T. Krarup, E. Christiansen, L. Kober, C. Nervil Kistorp, and C. Torp-Pedersen Insulin Therapy Improves Insulin-Stimulated Endothelial Function in Patients With Type 2 Diabetes and Ischemic Heart Disease Diabetes, November 1, 2001; 50(11): 2611 - 2618. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Z. Goldstein, B. E. Hurwitz, M. M. Llabre, N. Schneiderman, M. Gutt, J. S. Skyler, R. J. Prineas, and R. P. Donahue Modeling Preclinical Cardiovascular Risk for Use in Epidemiologic Studies: Miami Community Health Study Am. J. Epidemiol., October 15, 2001; 154(8): 765 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Virdis, L. Ghiadoni, H. Cardinal, S. Favilla, P. Duranti, R. Birindelli, A. Magagna, G. Bernini, G. Salvetti, S. Taddei, et al. Mechanisms responsible for endothelial dysfunction induced by fasting hyperhomocystinemia in normotensive subjects and patients with essential hypertension J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1106 - 1115. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Taddei, A. Virdis, L. Ghiadoni, A. Magagna, S. Favilla, A. Pompella, and A. Salvetti Restoration of Nitric Oxide Availability After Calcium Antagonist Treatment in Essential Hypertension Hypertension, March 1, 2001; 37(3): 943 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vehkavaara, J. Westerbacka, T. Hakala-Ala-Pietilä, A. Virkamäki, O. Hovatta, and H. Yki-Järvinen Effect of Estrogen Replacement Therapy on Insulin Sensitivity of Glucose Metabolism and Preresistance and Resistance Vessel Function in Healthy Postmenopausal Women J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4663 - 4670. [Abstract] [Full Text] |
||||
![]() |
S. Vehkavaara, S. Makimattila, A. Schlenzka, J. Vakkilainen, J. Westerbacka, and H. Yki-Jarvinen Insulin Therapy Improves Endothelial Function in Type 2 Diabetes Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 545 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ghiadoni, A. Virdis, A. Magagna, S. Taddei, and A. Salvetti Effect of the Angiotensin II Type 1 Receptor Blocker Candesartan on Endothelial Function in Patients With Essential Hypertension Hypertension, January 1, 2000; 35(1): 501 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E. Straznicky, C. J. O'Callaghan, V. E. Barrington, and W. J. Louis Hypotensive Effect of Low-Fat, High-Carbohydrate Diet Can Be Independent of Changes in Plasma Insulin Concentrations Hypertension, October 1, 1999; 34(4): 580 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Taddei, L. Ghiadoni, A. Virdis, S. Buralli, and A. Salvetti Vasodilation to Bradykinin Is Mediated by an Ouabain-Sensitive Pathway as a Compensatory Mechanism for Impaired Nitric Oxide Availability in Essential Hypertensive Patients Circulation, September 28, 1999; 100(13): 1400 - 1405. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Jensen and E. J. Messina C-peptide induces a concentration-dependent dilation of skeletal muscle arterioles only in presence of insulin Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1223 - H1228. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hasdai, D. R. Holmes Jr., D. M. Richardson, U. Izhar, and A. Lerman Insulin and IGF-I attenuate the coronary vasoconstrictor effects of endothelin-1 but not of sarafotoxin 6c Cardiovasc Res, September 1, 1998; 39(3): 644 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hasdai, R. A. Rizza, D. R. Holmes Jr, D. M. Richardson, P. Cohen, and A. Lerman Insulin and Insulin-like Growth Factor-I Cause Coronary Vasorelaxation In Vitro Hypertension, August 1, 1998; 32(2): 228 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Bonadonna, M. P. Saccomani, S. Del Prato, E. Bonora, R. A. DeFronzo, and C. Cobelli Role of Tissue-Specific Blood Flow and Tissue Recruitment in Insulin-Mediated Glucose Uptake of Human Skeletal Muscle Circulation, July 21, 1998; 98(3): 234 - 241. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Taddei, A. Virdis, L. Ghiadoni, A. Magagna, and A. Salvetti Vitamin C Improves Endothelium-Dependent Vasodilation by Restoring Nitric Oxide Activity in Essential Hypertension Circulation, June 9, 1998; 97(22): 2222 - 2229. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Laine, M. J. Knuuti, U. Ruotsalainen, T. Utriainen, V. Oikonen, M. Raitakari, M. Luotolahti, O. Kirvela, P. Vicini, C. Cobelli, et al. Preserved Relative Dispersion but Blunted Stimulation of Mean Flow, Absolute Dispersion, and Blood Volume by Insulin in Skeletal Muscle of Patients With Essential Hypertension Circulation, June 2, 1998; 97(21): 2146 - 2153. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Natali, A. Q. Galvan, N. Pecori, G. Sanna, E. Toschi, and E. Ferrannini Vasodilation With Sodium Nitroprusside Does Not Improve Insulin Action in Essential Hypertension Hypertension, February 1, 1998; 31(2): 632 - 636. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Scherrer and C. Sartori Insulin as a Vascular and Sympathoexcitatory Hormone : Implications for Blood Pressure Regulation, Insulin Sensitivity, and Cardiovascular Morbidity Circulation, December 2, 1997; 96(11): 4104 - 4113. [Abstract] [Full Text] |
||||
![]() |
S. Taddei, A. Virdis, L. Ghiadoni, S. Uleri, A. Magagna, and A. Salvetti Lacidipine Restores Endothelium-Dependent Vasodilation in Essential Hypertensive Patients Hypertension, December 1, 1997; 30(6): 1606 - 1612. [Abstract] [Full Text] |
||||
![]() |
K. T. Stepniakowski, G. Lu, G. D. Miller, and B. M. Egan Fatty Acids, Not Insulin, Modulate {alpha}1-Adrenergic Reactivity in Dorsal Hand Veins Hypertension, November 1, 1997; 30(5): 1150 - 1155. [Abstract] [Full Text] |
||||
![]() |
S. Taddei, A. Virdis, P. Mattei, L. Ghiadoni, C. B. Fasolo, I. Sudano, and A. Salvetti Hypertension Causes Premature Aging of Endothelial Function in Humans Hypertension, March 1, 1997; 29(3): 736 - 743. [Abstract] [Full Text] |
||||
![]() |
S. Taddei, A. Virdis, L. Ghiadoni, A. Magagna, and A. Salvetti Cyclooxygenase Inhibition Restores Nitric Oxide Activity in Essential Hypertension Hypertension, January 1, 1997; 29(1): 274 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J.J. Tack, J. A. Lutterman, G. Vervoort, T. Thien, and P. Smits Activation of the Sodium-Potassium Pump Contributes to Insulin-Induced Vasodilation in Humans Hypertension, September 1, 1996; 28(3): 426 - 432. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |